CompaniesNordic Nanovector

Nordic Nanovector

defunct
About

Defunct Company

Areas of Focus

Categories

MergedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

4

As Collaborator

0

Total Enrollment

216

By Phase

PHASE1: 3PHASE1/PHASE2: 1

By Status

COMPLETED: 3WITHDRAWN: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
NCT01796171
NCT02658968
NCT02657447
NCT03806179
Hover over trial bars to see details

Recent Trials

NCT03806179Lead Sponsor
Study of Safety and Efficacy of Betalutin and Rituximab in Patients With FL
PHASE1Completed
7 participants
Started: Oct 4, 2018 · Completed: Aug 8, 2022
NCT02657447Lead Sponsor
Dosimetry Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-02)
PHASE1Withdrawn
Started: Dec 19, 2017 · Completed: Sep 30, 2020
NCT02658968Lead Sponsor
Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)
PHASE1Completed
18 participants
Started: Mar 2, 2017 · Completed: Jul 10, 2021
NCT01796171Lead Sponsor
A Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma
PHASE1/PHASE2Completed
191 participants
Started: Dec 31, 2012 · Completed: Oct 27, 2022
Related Companies
Thor Medical
merged